International news agency
International News Services archives articles supplied to clients one year or more after initial publication. These articles are protected by a password and not made available to readers without permission from clients. They are used as a background resource by agency journalists. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.

Search Results for: Germany

10 results out of 3221 results found for 'Germany'.

EU ENERGY POLICY, BIOMASS, EMISSIONS TRADING, GLOBAL WARMING, SECURITY OF SUPPLY



BY DEIRDRE MASON

THE MEDIA rush to pick up on the revival of nuclear energy as a serious UK option, made plain in the Department of Trade and Industry’s recent Energy Review consultation document, has diverted attention from which tail will, in practice, be wagging the UK energy dog over the coming months.…

Read more

MIT BRAIN TUMOUR PATENT CASE - ECJ - GERMANY



BY KEITH NUTHALL
THE MASSACHUSETTS Institute of Technology (MIT) has won crucial support at the European Court of Justice (ECJ) in securing a supplementary protection certificate in Germany for brain tumour drug Gliadel. The MIT is appealing against the German Patent and Trade Mark Office’s blocking this protection, because the drug’s key active ingredient carmustine has been long established and Gliadel’s technological advance is combining it with biodegradable polifeprosan that regulates the release of this therapeutic material, rather than attacking tumours directly.…

Read more

WTO PATIENT COSTS POVERTY REPORT



BY KEITH NUTHALL

THE WORLD Health Organisation (WHO) is warning that around 100 million people fall into poverty every year because of medical care payments they cannot afford. It adds that an additional 150 million people spend nearly half their incomes on medical expenses.…

Read more

CANCER STEM CELL DRUG RESEARCH COOPERATION DEAL



BY KEITH NUTHALL
GERMANY’S Artemis Pharmaceuticals has agreed to help Spanish biotechnology company the Centre for Applied Molecular Research Salamanca (CIBASA) market CIBASA’s cancer stem cell based ‘Oncostem’ technology to pharmaceutical manufacturers developing novel anti-cancer therapies. CIBASA has a collection of cancer mouse models that show identical pathology to corresponding human cancers and similar responses to known therapeutic agents.…

Read more

WTO PATIENT COSTS POVERTY REPORT



BY KEITH NUTHALL

THE WORLD Health Organisation (WHO) is warning that around 100 million people fall into poverty every year because of medical care payments they cannot afford. It adds that an additional 150 million people spend nearly half their incomes on medical expenses.…

Read more

LOCAL AUTHORITY BROADBAND PROMOTION - EUROPEAN COMMISSION



BY KEITH NUTHALL

THE PROMOTORS of a European Commission-supported research project encouraging municipalities across Europe to establish local broadband services say their four trials have proved a success. The scheme is especially designed to help local authorities seed new comms tech investment in zones deemed too remote by commercial service providers for investing in infrastructure.…

Read more

EMCDDA ANNUAL REPORT - EUROPE DRUG USE REPORT



BY KEITH NUTHALL

THE EUROPEAN Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has highlighted Britain, Germany, Luxembourg, Hungary, Austria, and the only European Union (EU) countries offering drug addiction programmes for young offenders. These countries, its 2005 annual report noted approvingly, have "selective prevention programmes for first-time offenders (largely cannabis users), offering psychological support, training and counselling."…

Read more

WTO PATIENT COSTS POVERTY REPORT



BY KEITH NUTHALL
THE WORLD Health Organisation (WHO) is warning that around 100 million people fall into poverty every year because of medical care payments they cannot afford. It adds that an additional 150 million people spend nearly half their incomes on medical expenses.…

Read more

INTEGRATED POLLUTION CONTROL DIRECTIVE REPORT



BY KEITH NUTHALL
CONCERNS about delays in the implementation of a major piece of European Union (EU) environmental legislation have sparked a review by the European Commission, and will encourage it to pursue legal action in the courts. The law in question is the 1996 integrated pollution prevention and control directive, which insists large EU industrial and agricultural installations obtain operating permits – issued only if the best available techniques on controlling emissions are in use.…

Read more

EU DRINKS WHITE PAPER PLANS - PUBLIC HEALTH CONCERNS - DRINKS INDUSTRY LOBBYING



BY ALAN OSBORN

A MAJOR battle is looming over the European Union’s (EU) alcohol policy, with Britain seen by many as the major opponent of tougher anti-drink legislation amongst the 25 member states. A Communication (formal policy paper) ‘on a strategy on alcohol-related harm’ is being drawn up by the European Commission, but while this is not due for adoption before mid-2006, furious lobbying on both sides is already evident.…

Read more